Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes

International Journal of Molecular Medicine

Volumn 33, Issue 3, 2014, Pages 736-742

  Song, De Wei ^b   Xin, Nian ^a   Xie, Bing Jie ^a   Li, Yu Juan ^a   Meng, Ling Yan ^a   Li, Hong Mei ^b   Schläppi, Michael ^c   Deng, Yu Lin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

^b NATIONAL INSTITUTE OF METROLOGY   (China)

^c MARQUETTE UNIVERSITY   (United States)

Author keywords

1 acetyl 6 7 dihydroxy 1 2 3 4 tetrahydroisoquinoline; Diabetes; Hyperglycemia; Methylglyoxal; Parkinson's disease

Indexed keywords

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; GLUCOSE; HYDROXYL RADICAL; HYPERGLYCEMIA; ISOQUINOLINES; NEUROTOXINS; PARKINSON DISEASE; RATS; TETRAHYDROISOQUINOLINES;

EID: 84893826232     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1604     Document Type: Article

References (35)

1. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A and Chen H: Diabetes and Risk of Parkinson's Disease. Diabetes Care 34: 910-915, 2011.
2. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L and Ritz B: Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes Care 34: 1102-1108, 2011.
3. Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA and Bennett DA: Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology 63: 996-1001, 2004.
4. Deng YL, Zhang YQ, Li YJ, Xiao SY, Song DW, Qing H, Li Q and Rajput AH: Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains. J Neural Transm 119: 435-441, 2012.
5. Ristow M: Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 82: 510-529, 2004.
6. Deng YL and Rajput AM: 126th Annual Meeting, American Neurological Association: Abstracts: Plenary Session: Epilepsy. Ann Neurol 50 (Suppl 1): S19-S22, 2001.
7. Haik GM Jr, Lo TW and Thornalley PJ: Methylglyoxal concentration and glyoxalase activities in the human lens. Exp Eye Res 59: 497-500, 1994.
8. Zhu W, Wang D, Zheng J, An Y, Wang Q, Zhang W, Jin L, Gao H and Lin L: Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: Involvement in pathogenesis of Parkinson disease. Clin Chem 54: 705-712, 2008.
9. Zhang Y, Xiao S, Wang L, Wang H, Zhu Y, Li Y and Deng Y: Absolute quantification of semicarbazide-sensitive amine oxidase in human umbilical artery by single-reaction monitoring with electrospray tandem mass spectrometry. Anal Bioanal Chem 397: 709-715, 2010.
10. Wang R, Qing H, Liu XQ, Zheng XL and Deng YL: Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells. Neurosci Bull 24: 125-132, 2008.
11. Song DW, Du HQ, Wang L, Hu GF and Deng YL: Analysis of catechol quinoline substance in corpus striatum and hippocampus from brains of diabetic rat models by HPLC-MS. Chemistry 11: 1049-1052, 2010.
12. Song DW, Hu GF, Zhou Y, Wang HB, Wang L, Zhu Y and Deng YL: Proteomic analysis of proteins related to Parkinson's disease in the corpus striatum and hippocampus of diabetes rat model. Chemistry 6: 430-434, 2008.
13. Kuhla B, Loske C, Garcia De Arriba S, Schinzel R, Huber J and Münch G: Differential effects of 'Advanced glycation endproducts' and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y. J Neural Transm 11: 427-439, 2004.
14. Emdadul Haque M, Asanuma M, Higashi Y, Miyazaki I, Tanaka K and Ogawa N: Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta 1619: 39-52, 2003.
15. Collins MO, Yu L, Coba MP, Husi H, Campuzano I, Blackstock WP, Choudhary JS and Grant SGN: Proteomic analysis of in vivo phosphorylated synaptic proteins. J Biol Chem 280: 5972-5982, 2005.
16. Song DW, Li Q, Luan YJ, Niu LY, Qing H and Deng YL: Comparative proteomic analysis of neural stem cells between differentiating and undifferentiating to dopaminergic neuron. Complex Medical Engineering (CME). IEEE/ICME International Conference, 1817-1823, 2007.
17. Diez L, Livertoux MH, Stark AA, Wellman-Rousseau M and Leroy P: High-performance liquid chromatographic assay of hydroxyl free radical using salicylic acid hydroxylation during in vitro experiments involving thiols. J Chromatogr B Biomed Sci Appl 763: 185-193, 2001.
18. Ferger B, Spratt C, Earl CD, Teismann P, Oertel WH and Kuschinsky K: Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo. Naunyn Schmiedebergs Arch Pharmacol 358: 351-359, 1998.
19. Copeland RL Jr, Das JR, Kanaan YM, Taylor RE and Tizabi Y: Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res 12: 61-69, 2007.
20. Yi H, Maruyama W, Akao Y, Takahashi T, Iwasa K, Youdim MB and Naoi M: N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2. J Neural Transm 113: 21-32, 2006.
21. Maruyama W, Akao Y, Youdim MB, Davis BA and Naoi M: Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J Neurochem 78: 727-735, 2001.
22. Wanpen S, Kooncumchoo P, Shavali S, Govitrapong P and Ebadi M: Salsolinol, an endogenous neurotoxin, activates JNK and NF-kappaB signaling pathways in human neuroblastoma cells. Neurochem Res 32: 443-450, 2007.
23. Kheradpezhouh M, Shavali S and Ebadi M: Salsolinol causing parkinsonism activates endoplasmic reticulum-stress signaling pathways in human dopaminergic SK-N-SH cells. Neurosignals 12: 315-324, 2003.
24. Thornalley PJ, Jahan I and Ng R: Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem 129: 543-549, 2001.
25. Dmitriev LF and Dugin SF: Aldehydes and disturbance of carbohydrate metabolism: Some consequences and possible approaches to its normalization. Arch Physiol Biochem 113: 87-95, 2007.
26. Sheu KF, Ho HT, Nolan LD, Markovitz P, Richard JP, Utter MF and Frey PA: Stereochemical course of thiophosphoryl group transfer catalyzed by mitochondrial phosphoenolpyruvate carboxykinase. Biochemistry 23: 1779-1783, 1984.
27. Richard JP: Mechanism for the formation of methylglyoxal from triosephosphates. Biochem Soc Trans 21: 549-553, 1993.
28. Han YC, Randell E, Vasdev S, Gill V, Gadag V, Newhook LA, Grant M and Hagerty D: Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Mol Cell Biochem 305: 123-131, 2007.
29. MacDonald MJ, Chaplen FWR, Triplett CK, Gong Q and Drought H: Stimulation of insulin release by glyceraldehyde may not be similar to glucose. Arch Biochem Biophys 447: 118-126, 2006.
30. Caccese D, Pratico D, Ghiselli A, Natoli S, Pignatelli P, Sanguigni V, Luliano L and Violi F: Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation-role of arachidonic acid metabolism. Thromb Haemost 83: 485-490, 2000.
31. Shi HL and Liu KJ: Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia. Neurosci Lett 410: 57-61, 2006.
32. Adam W, Kurz A and Saha-Möller CR: Peroxidase-catalyzed oxidative damage of DNA and 2'-deoxyguanosine by model compounds of lipid hydroperoxides: Involvement of peroxyl radicals. Chem Res Toxicol 13: 1199-1207, 2000.
33. Hong JH, Kim MJ, Park MR, Kwag OG, Lee IS, Byun BH, Lee SC, Lee KB and Rhee SJ: Effects of vitamin E on oxidative stress and membrane fluidity in brain of streptozotocin-induced diabetic rats. Clin Chim Acta 340: 107-115, 2004.
34. Sima AAF and Li ZG: The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 54: 1497-1505, 2005.
35. Stevens MJ, Zhang W, Li F and Sima AA: C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab 287: E497-E505, 2004.